Skip to main content
Fig. 9 | Journal of Neuroinflammation

Fig. 9

From: Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model

Fig. 9

Effects of the IDO inhibitor 1-MT (9 mg/kg) on the kynurenine (KYN)/tryptophan (TRY) ratio in the hippocampus (a) and cerebral cortex (b) and on the serotonin (5-HT)/TRY ratio in the hippocampus (c) and cerebral cortex (d) of BDL rats. Data are expressed as mean ± SEM (n = 6). *p < 0.05, **p < 0.01, and ***p < 0.001, when compared to the sham group; #p < 0.05 and ##p < 0.01, when compared to the BDL group

Back to article page